Related references
Note: Only part of the references are listed.Agonist ligand discrimination by the two orexin receptors depends on the expression system
Jaana Putula et al.
NEUROSCIENCE LETTERS (2011)
Mapping the Binding Pocket of Dual Antagonist Almorexant to Human Orexin 1 and Orexin 2 Receptors: Comparison with the Selective OX1 Antagonist SB-674042 and the Selective OX2 Antagonist N-Ethyl-2-[(6-methoxy-pyridin-3-yl)-(toluene-2-sulfonyl)-amino]-N-pyridin-3-ylmethyl-acetamide (EMPA)
Pari Malherbe et al.
MOLECULAR PHARMACOLOGY (2010)
Orexin receptor antagonists: Medicinal chemistry and therapeutic potential
Anthony J. Roecker et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2008)
Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior
B Boutrel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A role for lateral hypothalamic orexin neurons in reward seeking
GC Harris et al.
NATURE (2005)
Distinct recognition of OX1 and OX2 receptors by orexin peptides
S Ammoun et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Development of an orexin-2 receptor selective agonist, [Ala11, D-Leu15]orexin-B
S Asahi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Identification and functional analysis of mutations in the Hypocretin (Orexin) genes of narcoleptic canines
M Hungs et al.
GENOME RESEARCH (2001)
Structure-activity analysis of truncated orexin-A analogues at the orexin-1 receptor
JG Darker et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Requirement of intact disulfide bonds in orexin-A-induced stimulation of gastric acid secretion that is mediated by OX1 receptor activation
T Okumura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Hypocretin (orexin) deficiency in human narcolepsy
S Nishino et al.
LANCET (2000)
Share Paper
